New Weight-Loss drug combo enters human testing – could it beat existing treatments?

NCT ID NCT06151964

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 22 times

Summary

This study tests a new drug called AZD9550, alone or with another drug (AZD6234), in 160 adults who are overweight or obese. Some participants also have type 2 diabetes. The main goals are to check safety, side effects, and how the drugs move through the body. This is an early-stage trial (Phase 1/2) to find the right doses and see if the combination helps with weight loss.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    COMPLETED

    Graz, 8036, Austria

  • Research Site

    COMPLETED

    Vienna, 1090, Austria

  • Research Site

    RECRUITING

    Surrey, British Columbia, V3T 4G8, Canada

  • Research Site

    RECRUITING

    Hamilton, Ontario, L8L 5G8, Canada

  • Research Site

    RECRUITING

    Sarnia, Ontario, N7T 4X3, Canada

  • Research Site

    RECRUITING

    Stouffville, Ontario, L4A 1H2, Canada

  • Research Site

    RECRUITING

    Toronto, Ontario, M4G 3E8, Canada

  • Research Site

    COMPLETED

    Sherbrooke, Quebec, J1L 0H8, Canada

  • Research Site

    ACTIVE_NOT_RECRUITING

    Magdeburg, 39120, Germany

  • Research Site

    ACTIVE_NOT_RECRUITING

    Neu-Ulm, 89231, Germany

  • Research Site

    ACTIVE_NOT_RECRUITING

    Neuss, 41460, Germany

  • Research Site

    COMPLETED

    Fukuoka, 812-0025, Japan

  • Research Site

    COMPLETED

    Shinjuku-ku, 160-0004, Japan

  • Research Site

    COMPLETED

    Suita-shi, 565-0853, Japan

  • Research Site

    COMPLETED

    Uppsala, 752 37, Sweden

Conditions

Explore the condition pages connected to this study.